Although myxopapillary ependymomas are classified as benign tumors, dissemination, and local recurrence pose a major challenge in their clinical treatment.

Therefore, a close follow-up of the patients with myxopapillary ependymoma is mandatory in order to detect local recurrent or spread of the tumor.